Several reports (1-3) where large molecular weight natural-occurring antigens and markedly heterogeneous antigenic material were used have demonstrated a statistically significant relationship of genetic factors to the immune response. More recently Levine, Ojeda, and Benacerraf (4, 5) have been able to demonstrate a genetic control of the immune response of guinea pigs immunized with hapten-poly-L-lysine conjugates.
(From the Department of Pathology, School of Medicine, University of California, Los Angeles)
(Received for pubfication, June 1, 1965) Several reports (1) (2) (3) where large molecular weight natural-occurring antigens and markedly heterogeneous antigenic material were used have demonstrated a statistically significant relationship of genetic factors to the immune response. More recently Levine, Ojeda, and Benacerraf (4, 5) have been able to demonstrate a genetic control of the immune response of guinea pigs immunized with hapten-poly-L-lysine conjugates.
Previous evidence (6) from this laboratory demonstrated that rabbits and guinea pigs produce insulin antibodies toward several determinants on the insulin molecule. The portions of the insulin molecule toward which antibodies were produced appeared to be an individual characteristic which varied from animal to animal. It was therefore postulated that genetic factors controlled insulin antibody production. Supporting evidence (7) for genetic control of insulin antibody production demonstrated that inbred strain 2 guinea pigs produced antibodies to portions of beef insulin to which strain 13 guinea pigs could not produce antibodies.
Additional supporting evidence that genetic factors control the configuration of the combining sites of insulin antibodies produced by guinea pigs is presented in this communication. Data consistent with the possibility that control of the antibody-combinlng site configuration may involve more than one gene and not multiple alleles at a given gene locus is also presented.
Methods and Materials
Antigens.--lmsulin: Two preparations of insulin were used in these studies. Lilly insulin (Lot 917106) 1 was a preparation of zinc crystals of beef insulin with a potency of 27.0 units/mg. Novo insulin (Lot 03355) 2 was a commercial preparation~ of 10 times recrystallized beef insulin with a biological potency of 22.0 units/mg. * Presented in part before the 49th Annual Meeting of the Federation of American Societies for Experimental Biology, April 9 through 14, 1965 . (abstract, Fed. Proc., 1965 .
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2 We wish to thank Mr. H. Juncher, Novo Industri A/S, Copenhagen, Denmark, for the generous supply of 10 X crystalline beef insulin. 771 o ! the method of Eylar a a]. (9) . It was divided into 2 ml aliquots and stored at --80 C. Ca preparations maintained their complement activity for at least 6 months when prepared in this
Titration of complement (10) : Tlters of Ca were determined by 50 per cent hemolytic end points. A unit of complement is defined as the smallest amount of Ca which will cause lysls of 50 per cent of the sensitized cells (1 ml of a 1.25 per cent suspension) in a final volume of 1.5 ml after 30 minutes at 37°C.
Erythrocyte preparation: Sheep red cells were stored as sheep blood collected in an equal volume of Alsever's solution (11) . This suspension was stored at 4°C and used for a period of 14 days.
Bis.diazo-bozz~ine (BDB):
BDB was prepared by a modification of the method described by Kabat and Mayer (12) . To prepare approximately 200 ml stock BDB, 0.92 gm benzidlne and approximately 6.8 ml sodium nitrite were used. The reaction was carried out in the presence of ice crystals. The final product was a pale yenow solution. This material was empirically standardized by adding 7 ml of 0.11 x¢ phosphate buffer pH 7.4 to 0.5 ml BDB (1:15 BDB). A deep reddish brown color developed immediately and the solution became turbid within 90 seconds (-i-S seconds). In the event the solution did not immediately turn deep reddish brown, the onset of turbidity was also prolonged, A few crystals of benzidine were then added and the solution retested. When the turbidity developed rapidly (less than 80 seconds), small amounts of sodium nitrite were added to the solution. When the desired preparation was obtained, the stock BDB was divided into 0.S ml aliquots and stored at --80°C. Under these conditions BDB was active for at least 9 months.
Preparation of insulin-sensitized erythrocyles (insulin cells): Insulin cells were prepared by
conjugating insulin to the surface of washed sheep erythrocytes with bis-diazo-benzidine, as previously described (13) .
Titration of insulin antibody actldty:
Insulin antibodies were measured by a modification of the immune hemolysis teehn{que pre.vlously described (6) . The hemolysis of insulin cells
by antibodies m the presence of excess Cs has been shown to be proportional to antibody concentration with this method. Antisera, serially diluted with VBS to a final volume of 0.5 ml, were cooled in an ice bath and 20 50 per cent hemolytic s units of Ca in 0.3 ml were then added. Finally the cells (0.2 ml of a 2.5 per cent suspension) were added and evenly suspended by gentle shaking. All samples in a given experiment were incubated in a 370C water bath for 30 minutes, the non-hemolyzed cells separated by centrifugation at 3°C at approximately 2000 g for 5 minutes, and the supernatant solutions decanted into 2 ml of water. The degree of hemolysis was measured by the extinction of each sample at 580 m/z with a Beckman model DB spectrophotometer.
By measuring the area of the hemolytic titration curve, it is possible to obtain precise measurements of relative antibody concentrations (6) . The hemolytic titration curve areas obtained from 5 aliquots of the same antiserum simultaneously tested were estimated by planimetry. The standard deviation calculated from the mean area of the 5 aliquots was found to be :t:1.5 per cent.
Preparation of insulin-cellulose (IC) aggregate with BDB:
Insulin (60 rag) was dissolved in 10 ml 0.01 ~ NaOH, to which 10 ml 0.22 ~ phosphate buffer pH 7.4 was then added. This solution was cooled in an ice bath and while constantly being stirred 0.5 ml of stock BDB was added. Theoretically this should have resulted in equimolar concentrations of insulin and BDB assuming insulin to have a molecular weight of 6000. After 20 minutes incubation, 280 nag of PABC (p-aminobenzyl ether of cellulose) obtained from the California Corp. for Biochemieal Research, Los Angeles (cellex PAB) were added to the insulin-BDB solution. This mixture was incubated at 4°C for approximately 18 hours, with constant stirring. The PABC-BDBinsulin (IC) was then washed 6 times with distilled water. The washed IC was suspended in 3.4 ml of VBS containing 150 mg per cent bovine serum albumin (VBS-alb) and stored at 4oC.
To prepare the antibody-saturated insulin aggregate (AB.-IC), 0.3 ml of the stock IC was diluted with 15 ml of VBS-alb, centrifuged at approximately 2000 g for 10 minutes at 4°C, and the supematant discarded. Three aliquots (2 ml) of insulin antiserum were then successively incubated with IC for 15 minutes at room temperature while being shaken. Following the last incubation with the third aliquot of saturating antiserum and subsequent centrifugation, the AB,-IC was evenly suspended in 8 ml of VBS-alb, divided into eight 1 ml aliquots, centrifuged, and the supematants discarded. Diluted antisera (AB0 were added to the 8 ABa-IC aliquots to test for the presence of antibodies capable of binding to exposed antigenic determinants on the AB6-IC.
RESULTS
Experimental Procedure.--These experiments were designed to test whether genetic factors control the configuration of the combining sites of insulin antibodies from inbred str 2, str 13 guinea pigs, the Fx (str 2 X str 13), and F, (F1 X Fz) hybrids.
Differences in configuration of the insulin antibody-combining sites were discerned by measuring the percentage of antibodies in a test antiserum (AB0 which bound to the exposed insulin determinants on an insoluble insulin complex (IC) which had been saturated with antibodies from a different antiserum (AB.).
The detMls of this system have been previously described (6).
In a typical experiment an aliquot of stock insoluble insulin aggregate (IC) is saturated with antibodies from a single antiserum (AB,) to form an insulin aggregate saturated with antibodies (AB,-IC). Aliquots of AB,-IC (usually 8) are each incubated with various test antisera (ABt). If a significant percentage of antibodies in the ABt are bound to the AB,-IC it is assumed that the test antiserum contained antibodies which conformed to antigenic determinants to which the antibodies in AB, could not conform. Such antibodies were considered to have combining-site configurations different from any of the antibodies in AB,.
The validity of these experiments requires that the IC be saturated with antibodies from the saturating antiserum (AB,) prior to the addition of the test antiserum AB,. In all experiments, saturation of IC with AB, was accomplished by repeatedly incubating IC with 3 fresh aliquots of ABe. In the vast majority of experiments the IC appeared to be saturated with insulin antibodies following the second incubation. The supernatant ABs aliquot following the third incubation very rarely showed a decrease in insulin antibodies. Saturation was not accomplished on two occasions when very low titered ABs was employed; these results were considered not valid.
Theper cent binding of ABe to AB~-IC was calculated as previously described (6) $ This pool was a combination of approximately equal aliquots of anfisera from 5 str 13 guinea pigs. dissociated resulting in a net decrease in the immune hemolysis fiter of incubated ABt. Evidence has been presented (6) demonstrating that decreased immune hemolysis titers of incubated AB, are not due to dissociation of insulin antibodies from AB~-IC during the period of incubation with the test antisera.
Under these circumstances the following criteria were considered necessary to support the postulate that genetic factors control the configuration of the insulin antibody-combining sites in guinea pigs:
1. No differences in configuration of antibody-combining site should be demonstrable in guinea pigs of the same strain; i.e., str 2 ABt should not bind to str 2 AB,-IC or str 13 ABt should not bind to str 13 ABB-IC.
2. Differences in configuration of antibody-combining site should be demonstrable when antisera from str 2 guinea pigs are compared to antisera from str 13 guinea pigs.
3. Segregation of such differences in configuration of antibody-combining sites should be demonstrable when insulin antibodies from hybrid guinea pigs (Ft and F,) were compared to insulin antibodies from str 2 and str 13 parents. :~ Str 2 (C) and Str 13 (D) antiserum pools previously described, see Table I . Table I summarizes the results observed in a group of experiments in which str 2 antisera were tested against insulin aggregates saturated with str 2 antibodies and str 13 antisera were tested against insulin aggregates saturated with str 13 anfisera.
Similarity in Combining Sites of Insulin Antibodies Produced by Guinea Pigs of the Same Strains.--
Ten experiments were performed testing the binding of insulin antibodies from 8 individual and 1 pooled str 2 anfisera (AB0 to insulin aggregates which had been saturated with antibodies from 4 individual and 1 pooled str 2 antisera (AB,-IC). None of the 9 str 2 test antisera (ABt) contained demonstrable antibodies with combining sites different than the antibodies in the 5 str 2 (Table I) .
Likewise, in 10 experiments none of 9 test antisera (ABt) from str 13 guinea pigs contained significant amounts of insulin antibodies capable of binding to AB.-IC saturated with insulin antibodies from 6 str 13 (Table I) .
Because of the shortage of inbred animals it was necessary and also considered desirable to use a pooled str 2 and a pooled str 13 antiserum in these experiments. The str 2 pool was made up of approximately equal aliquots of antisera These experiments indicate that inbred guinea pigs of the same strain produce antibodies toward similar determinants on the insulin molecule. Consequently, it is probable that the configurations of the combining sites of insulin antibodies produced by guinea pigs are similar in animals of the same strain.
Configurational Differences of Combining Sites of Insulin Antibodies from Sir 2 and Str 13 Guinea
Pigs.--Differences in combining sites of insulin antibodies from str 2 guinea pigs tested against insulin aggregates saturated with antibodies from str 13 guinea pigs could not be demonstrated. Nor were differences in combining sites of antibodies from str 13 guinea pigs noted when tested against ABs-IC saturated with antibodies from str 2 guinea pigs (Table II) .
In 14 experiments where 9 str 13 antisera were tested against insulin aggregates saturated with 6 different str 2 antisera, none of the str 13 antisera contained significant amounts of antibodies capable of binding to insulin aggregates saturated with antibodies from str 2 antisera. Likewise, in 13 experiments, with 9 str 2 AB,, no demonstrable antibodies were noted which were capable of binding to ABs-IC saturated with 6 str 13 ABe. Therefore, in 27 experiments, differences between str 2 and str 13 could not be demonstrated directly (Table  II) .
Coniigurational differences of insulin antibody combining sites between str 2 and str 13 guinea pigs were noted only when tested against 2 insulin aggregates, each saturated with antibodies from one of 2 partially inbred rabbits (A01 and A02) Table III . In 12 experiments, each of 6 different str 2 antisera contained antibodies which bound (25 to 95 per cent) to portions of the insulin molecule to which antibodies from neither of the 2 rabbits could bind. Whereas, in 8 experiments, none of the str 13 antisera contained significant (10 per cent or more) amounts of antibodies which could bind to either of the 2 insulin aggregates saturated with antibodies from the partially inbred rabbits. Therefore, str 2 guinea pigs produce antibodies to portions of the insulin molecule to which str 13 guinea pigs cannot produce antibodies.
The results suggest that str 2 guinea pigs produce antibodies to antigenic sites on insulin which axe in close proximity to the binding sites of the antibodies produced by str 13 guinea pigs. The inability to demonstrate binding of antibodies from str 2 guinea pigs to insulin aggregates saturated with str 13 antibodies and vice versa is probably best explained by overlap of the respective antigenic determinants and interference due to steric hindrance. The determinants on insulin of antibodies from the partially inbred rabbits are probably in close proximity to the determinants of the antibodies from str 13 guinea pigs but more distant from the determinants of antibodies produced by str 2 guinea pigs. Consequently, antibodies in AB, from str 13 animals did not bind and antibodies in AB, from str 2 animals did bind to AB~-IC saturated with antibodies from partially inbred rabbits. It therefore is likely that the configurations of the combining sites of a significant percentage of insulin antibodies in str 2 antisera are different than the configurations of the antibodies in str 13 antisera.
Combining Site Overlap of Insulin Antibodies Produced by F1 Offspring Compared to Antibodies Produced by Str 2 and Str 13 Guinea Pigs--Twenty-seven
experiments employing 9 individual F1 antisera were done against 2 AB s-IC saturated with 2 str 2 ABB and also against 2 AB~-IC saturated with 2 str 13 AB, (Table IV) . One of the str 2 ABB was a pool made up of antisera from 7 animals, and one of the str 13 AB. was a pool made up of anfisera from 5 animals. One Fx antiserum (46) contained significant amounts of antibodies with combining sites different than the antibodies in both str 13 AB,.This same antiserum (46) did not contain insulin antibodies with combining sites different than the two str 2 AB,. One other FI animal (40) contained (6 per cent) a few (not significant) antibodies which combined with insulin sites different from Table I. those saturated with str 2 antiserum pool. Therefore, in 24 of 27 experiments, antibodies in the F1 antisera conformed to determinants on the insulin molecule in close proximity to the determinants with which the antibodies in str 2 or str 13 antisera conformed. It is not known whether the significantly different combining sites of the antibodies in the one (46) F1 antiserum is a true characteristic of F1 antisera or whether an unrecognized error in breeding may have taken place. It appears, therefore, that the great majority (possibly all) of insulin antisera from F1 (str 2 X str 13) hybrids do not contain discernable antibodies capable of binding to exposed determinants on insulin aggregates saturated with antibodies produced by str 2 or str 13 animals. Consequently, the configuration of the insulin antibody-combining sites of F1 animals is not sufficiently different from the configuration of antibody combining sites from str 2 and str 13 animal to be demonstrable in these experiments.
Configurational Differences of Combining Sites of Insulin Antibodies Produced by F2 Animals Compared to Antibodies Produced by Sir 2 and Str 13 Guinea
Pigs.--Segregation of the differences in antibody-combining site configuration was noted when F2 (FIX F1) antisera were tested against AB,-IC saturated with str 2 and str 13 antisera (Table V) . Such differences were noted in 11 of 22 experiments in which 7 F2 ABt were tested against 2 str 2 AB,-IC and also against 4 str 13 AB,-IC (Table V) . The pooled str 2 AB, and str 13 AB, used in Designates the number of test antisera in which 10 per cent or more of the insulin antibodies bound to exposed antigenic sites on AB~-IC. these experiments were aliquots of the same pooled antisera previously described.
Two (62 and 64) of the F, ABt contained a significant percentage of insulin antibodies with combining site configurations different from the antibodies in str 2 and also str 13 antisera. One (61) of the F2 AB, contained insulin antibodies with combining site configurations different from the str 2 antibodies but similar to the str 13 antibodies. The remaining 4 (63, 65-67) F, antisera contained insulin antibodies to determinants which overlapped the determinants to which the insulin antibodies in both str 2 and str 13 AB, were directed.
It appears therefore, that F2 offspring are capable of producing antibodies directed to portions of the insulin molecule to which neither of the inbred grandparents can make antibodies. These findings, therefore, are consistent with the possibility that the configuration of the antibody-combining site in guinea pigs is controlled by more than one gene and not by different alleles at a given gene locus.
Overlapping of Insulin Antibody-Combining Sites of FI and F~ Animals Corn-pared to Antibody-Combining Sites of Related
Animals.--The combining sites of insulin antibodies engendered in Ft (str 2 × str 13) guinea pigs were found to differ from the combining sites of antibodies from inbred parents when the F1 antisera were used to saturate insulln aggregate (Table VI) . Str 2 and str 13 ABa overlapped most FI ABt (Table IV) , and only half of the F2 ABt (Table  V) . In these experiments, 4 different F~ ABcIC's were prepared and tested against 4 str 2, 5 str 13, and 6 F~ test antisera (ABe) in a total of 25 experiments, Table VI . Ft animals apparently produced antibodies which overlap or sterically hinder the binding of insulin antibodies from both inbred parents and also their hybrid offspring (F~). In this regard, the antibodies produced by F1 animals are different from the antibodies produced by str 2 and str 13 parents. Most (possibly all) F1 animals produce antibodies which are not capable of binding to AB sic saturated with str 2 or str 13 AB, (Table IV) . Whereas, about half of Fx animals produce antibodies capable of binding to ABs-IC saturated with str 2 or str 13 AB~ (Table V) . None of 6 F2 AB~ contained antibodies which bound to any of 4 Fl AB,-IC in 11 experiments (Table VI) . It appears, therefore, that the Fx hybrid antibodies have combining sites which conform to more determinants on the insulin molecule than both of the inbred parents. However, the combining sites of antibodies produced by F~ animals are not sufficiently different to be capable of binding to either str 2 or str 13 AB,-IC.
A total of 38 experiments were performed with 5 F~ AB,-IC and ABt from 4 str 2, 4 str 13, and 9 F1 guinea pigs (Table VI) . The F~ antisera were capable of overlapping and preventing antibodies of all the ABt tested from reacting with antigenic sites on the insulin molecule. Since the F2 animals produce antibodies which react with both str 2 and str 13 AB~-IC (Table V) , it would appear that F~ offspring can make antibodies which conform to a greater number of antigenic sites on the insulin molecule than antibodies produced by F1 animals.
It appears, therefore, that the variations in configurations of the insulin antibody-combining sites of F1 animals are intermediate in comparison with F2 animals.
These observations are considered to be additional evidence that genetic factors control the configuration of the insulin antibody-combining sites.
Insulin Antibody-Combining Sites of F1 and F~ Hybrid Guinea Pigs Compared to Antibody-Combining Sites from Other F1 and F~ Animals Respectively.--Nineteen experiments were performed in which 9 F1 AB, were tested against 4 FI AB,-IC. One F1 ABt (46) antiserum contained significant amounts of antibodies with combining site configurations different than the F1 AB~ (43) used to saturate the IC (Table VII) . It is interesting that this is the same and only Fx animal (46) whose antiserum contained significant amounts of antibodies with combining site configurations different than inbred str 13 animals (Table IV) . It is possible that the combining site differences in the antibodies from this Fx (46) guinea pig are a true characteristic of F1 antisera. It is probably more tenable in view of the marked disparity with respect to all the other 8 F~ animals to tentatively explain the unique characteristics of Fx (46) antibodies as due to an unrecognized error in breeding. In which case it would be likely that the configurations of the combining sites of insulin antibodies amongst Ft animals are similar to each other. It is anticipated that with additional Fx animals this tentative explanation will be substantiated.
Twelve experiments were performed where F2 antisera were compared with each other (Table VII) . Two different AB, (F2 64 and 67) were found to have antibodies with combining site confgurafions different from one F~B, (65). Such differences were not demonstrable in the remaining 10 experiments. In this regard, it is interesting that such differences were found in 4 of 21 experiments with mongrel guinea pigs (6) .
Much larger groups of Fx and F, n nlmals must be tested to establish similarity of insulin antibody-combining sites amongst Fx animals and differences amongst F, animals. With the exception of one of the 31 experiments performed, the results observed here are consistent with the other results which have been presented.
DISCUSSION
No configurational differences of antibody-combining sites were noted in guinea pigs of the same strain (Table I ). Confignrational differences in insulin antibody-combining sites were noted between str 2 and str 13 guinea pigs (Table III) . Segregation of differences in antibody combining site configurations was noted in FI and F2 guinea pigs (Tables V and VI) . It is therefore, quite probable that genetic factors control the configuration of insulin antibodycombining sites in guinea pigs.
Furthermore, insulin antibody-combining sites from F2 animals can have configurations that are different from the configurations of insulin antibodies noted in either of the 2 inbred parental strains (Table V) . It is therefore also possible that the configurations of the combining sites of insulin antibodies produced in guinea pigs is controlled by more than one gene and not by multiple alleles at a given gene locus.
It is possible that these configuration differences of the F2 antibodies may be due to segregation of residual heterozygosity of the parental inbred str 2 and str 13. No significant quantitative or qualitative differences were noted within either of these strains (Table I) . Consistent quantitative differences, however, were noted in the amounts of antibodies amongst the various str 2 AB~ that bound to both AB B-IC saturated with partially inbred rabbit antisera. Whether such quantitative differences are an expression of residual heterozygosity may possibly be discerned by comparisons within and between different familial lines of the inbred str 2 and str 13 animals.
Considerable evidence recently reviewed by Edelman and Gally (14) suggests that the configuration of the antibody-combining site of gG is formed by sequences of amino acids in contiguous portions of both the light (~) and heavy (5') chains. In which case, it would be likely that at least 2 genes are involved in dictating the configuration of the antibody-combining site of gG.
The results presented here are in one way or another probably an expression of all the immunoglobulins in the antisera which are employed. Sufficient animals have not been used to estimate the number of genes involved in determining the configuration of the combining sites of the guinea pig insulin antibodies. It is therefore unwarranted to relate these results to the well documented (15) structure of human and rabbit gG.
These experiments are concerned only with the binding of antibodies to insulin. It would be presumptive therefore to speculate at which stage or stages of immunization the gene or genes involved influence the insulin antibodycombining site differences which have been demonstrated in these experiments. SUMMARy 1. Genetic factors control the configuration of combining sites of guinea pig insulin antibodies.
2. It is possible that the configuration of the combining sites of guinea pig insulin antibodies is controlled by more than one gene and not by multiple alleles at a given gene locus. 
